Graft versus Host Disease Market to Increase at a CAGR of 9.9% During the Study Period (2020–2034) | DelveInsight [Yahoo! Finance]
Equillium, Inc. (EQ)
Last equillium, inc. earnings: 3/26 04:07 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
New York, USA, Sept. 22, 2024 (GLOBE NEWSWIRE) -- Graft versus Host Disease Market to Increase at a CAGR of 9.9% During the Study Period (2020–2034) | DelveInsight The graft versus host disease market is experiencing significant growth, driven by the ongoing adoption of branded therapies such as JAKAFI, IMBRUVICA, ORENCIA, and REZUROCK compared to off-label drugs, a strong pipeline with the anticipated launch of over 10 new drugs during the forecast period, and increased awareness of GvHD management. Innovative treatments and ongoing research are expected to further expand market opportunities, addressing unmet needs in this complex condition. DelveInsight's Graft versus Host Disease Market Insights report includes a comprehensive understanding of current treatment practices, graft versus host disease emerging drugs, market share of individual therapies, and current and forecasted graft versus host disease market size from 2020 to 2034, segmented into 7MM [The United States, the
Show less
Read more
Impact Snapshot
Event Time:
EQ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EQ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EQ alerts
High impacting Equillium, Inc. news events
Weekly update
A roundup of the hottest topics
EQ
News
- Equillium, Inc. (EQ) to Report Q3 Results: Wall Street Expects Earnings Growth [Yahoo! Finance]Yahoo! Finance
- Equillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of CancerBusiness Wire
- Equillium collaborates with Vivtex for oral formulation of autoimmune therapy [Yahoo! Finance]Yahoo! Finance
- Equillium to Present at the Stifel Virtual Inflammation & Immunology SummitBusiness Wire
- Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Business Wire
EQ
Earnings
- 5/9/24 - Beat
EQ
Analyst Actions
- 8/19/24 - HC Wainwright
EQ
Sec Filings
- 10/29/24 - Form 4
- 9/27/24 - Form 4
- 9/17/24 - Form 4
- EQ's page on the SEC website